ReviewFuture medicinal chemistry2010
Advantages of macromolecular to nanosized chemical-exchange saturation transfer agents for MRI applications.
Review in Future medicinal chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 29 citations in OpenAlex.
- Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review).International journal of oncology · 2025Review
- Design Chemical Exchange Saturation Transfer Contrast Agents and Nanocarriers for Imaging Proton ExchangeACS nano · 2024Review
- Nanomedicine Particles Associated With Chemical Exchange Saturation Transfer Contrast Agents in Biomedical Applications.Frontiers in chemistry · 2020Review
- pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.Magnetic resonance in medicine · 2016Article
- Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain.NeuroImage · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
Chemical-exchange saturation transfer (CEST) agents are a new class of MRI contrast agents that offer a number of advantages over conventional Gd(3+) agents. Over the past few years, a variety of small-molecule CEST agents responsive to physiological conditions, such as pH and temperature, have been designed and their imaging applications have been reported. One of the major drawbacks of current small-molecule CEST agents is their relatively low sensitivity. The advantages of using macromolecular and nanosized systems with large numbers of exchangeable groups to improve contrast sensitivity are highlighted in this brief review. Although this approach has been shown to amplify contrast sensitivity, other limitations, including relatively small chemical-shift differences between the exchanging species and bulk water and less than optimal proton exchange rates, still exist. By addressing these issues, it is anticipated that CEST agents will find useful applications in the detection of specific biomarkers of disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.